143 related articles for article (PubMed ID: 21959232)
1. Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivatives.
Csuk R; Schwarz S; Siewert B; Kluge R; Ströhl D
Eur J Med Chem; 2011 Nov; 46(11):5356-69. PubMed ID: 21959232
[TBL] [Abstract][Full Text] [Related]
2. Does one keto group matter? Structure-activity relationships of glycyrrhetinic acid derivatives modified at position C-11.
Csuk R; Schwarz S; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2012 Jan; 345(1):28-32. PubMed ID: 22076975
[TBL] [Abstract][Full Text] [Related]
3. Improvement of the cytotoxicity and tumor selectivity of glycyrrhetinic acid by derivatization with bifunctional amino acids.
Csuk R; Schwarz S; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2011 Aug; 344(8):505-13. PubMed ID: 21674592
[TBL] [Abstract][Full Text] [Related]
4. Conversions at C-30 of glycyrrhetinic acid and their impact on antitumor activity.
Csuk R; Schwarz S; Siewert B; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2012 Mar; 345(3):223-30. PubMed ID: 21997717
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
Schwarz S; Csuk R
Bioorg Med Chem; 2010 Nov; 18(21):7458-74. PubMed ID: 20932766
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
Csuk R; Schwarz S; Kluge R; Ströhl D
Eur J Med Chem; 2010 Dec; 45(12):5718-23. PubMed ID: 20884085
[TBL] [Abstract][Full Text] [Related]
7. Alkylidene branched lupane derivatives: synthesis and antitumor activity.
Csuk R; Stark S; Nitsche C; Barthel A; Siewert B
Eur J Med Chem; 2012 Jul; 53():337-45. PubMed ID: 22578785
[TBL] [Abstract][Full Text] [Related]
8. N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
Lallemand B; Chaix F; Bury M; Bruyère C; Ghostin J; Becker JP; Delporte C; Gelbcke M; Mathieu V; Dubois J; Prévost M; Jabin I; Kiss R
J Med Chem; 2011 Oct; 54(19):6501-13. PubMed ID: 21888390
[TBL] [Abstract][Full Text] [Related]
9. 18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells.
Lin KW; Huang AM; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2011 Jul; 19(14):4274-85. PubMed ID: 21696969
[TBL] [Abstract][Full Text] [Related]
10. 18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines.
Lee CS; Yang JC; Kim YJ; Jang ER; Kim W; Myung SC
Eur J Pharmacol; 2010 Dec; 649(1-3):354-61. PubMed ID: 20868669
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents.
Lai Y; Shen L; Zhang Z; Liu W; Zhang Y; Ji H; Tian J
Bioorg Med Chem Lett; 2010 Nov; 20(22):6416-20. PubMed ID: 20932754
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Antiproliferative Activity of Novel A-Ring Cleaved Glycyrrhetinic Acid Derivatives.
Alho DPS; Salvador JAR; Cascante M; Marin S
Molecules; 2019 Aug; 24(16):. PubMed ID: 31416117
[TBL] [Abstract][Full Text] [Related]
13. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity.
Lee CS; Kim YJ; Lee MS; Han ES; Lee SJ
Life Sci; 2008 Sep; 83(13-14):481-9. PubMed ID: 18721818
[TBL] [Abstract][Full Text] [Related]
14. The synthesis of 18beta-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells.
Liu D; Song D; Guo G; Wang R; Lv J; Jing Y; Zhao L
Bioorg Med Chem; 2007 Aug; 15(16):5432-9. PubMed ID: 17566745
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pro-apoptotic activity of novel glycyrrhetinic acid derivatives.
Logashenko EB; Salomatina OV; Markov AV; Korchagina DV; Salakhutdinov NF; Tolstikov GA; Vlassov VV; Zenkova MA
Chembiochem; 2011 Mar; 12(5):784-94. PubMed ID: 21328513
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxicity studies of novel 2-Hydrazonylpyrido[2,3-b]pyrazin-3(4H)-ones.
Zhang G; Liu Y; Wang S; Zhou C; Huang Q; Gong P
Arch Pharm (Weinheim); 2012 Jan; 345(1):49-56. PubMed ID: 21953529
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of an antitumor active endoperoxide from 11-keto-beta-boswellic acid.
Csuk R; Niesen-Barthel A; Barthel A; Kluge R; Ströhl D
Eur J Med Chem; 2010 Sep; 45(9):3840-3. PubMed ID: 20538386
[TBL] [Abstract][Full Text] [Related]
19. Quinazoline-tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Masand V; Al-Jaber NA; Ben Hadda T; Mohamed MA
Eur J Med Chem; 2012 Jul; 53():133-40. PubMed ID: 22520152
[TBL] [Abstract][Full Text] [Related]
20. Methyl 2-cyano-3,11-dioxo-18 beta-olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells.
Papineni S; Chintharlapalli S; Safe S
Mol Pharmacol; 2008 Feb; 73(2):553-65. PubMed ID: 17989348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
